BG63488B1 - Таблети с високо съдържание на фамцикловир - Google Patents

Таблети с високо съдържание на фамцикловир Download PDF

Info

Publication number
BG63488B1
BG63488B1 BG102638A BG10263898A BG63488B1 BG 63488 B1 BG63488 B1 BG 63488B1 BG 102638 A BG102638 A BG 102638A BG 10263898 A BG10263898 A BG 10263898A BG 63488 B1 BG63488 B1 BG 63488B1
Authority
BG
Bulgaria
Prior art keywords
tablet
famciclovir
tablets
content
phamcyclovir
Prior art date
Application number
BG102638A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG102638A (en
Inventor
Michael GREENWAY
Jennifer SLATER
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of BG102638A publication Critical patent/BG102638A/xx
Publication of BG63488B1 publication Critical patent/BG63488B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BG102638A 1996-01-16 1998-07-15 Таблети с високо съдържание на фамцикловир BG63488B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9600847.9A GB9600847D0 (en) 1996-01-16 1996-01-16 Pharmaceuticals
PCT/EP1997/000195 WO1997025990A1 (en) 1996-01-16 1997-01-13 High-content famciclovir tablets

Publications (2)

Publication Number Publication Date
BG102638A BG102638A (en) 1999-07-30
BG63488B1 true BG63488B1 (bg) 2002-03-29

Family

ID=10787105

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102638A BG63488B1 (bg) 1996-01-16 1998-07-15 Таблети с високо съдържание на фамцикловир

Country Status (38)

Country Link
US (1) US6765007B1 (es)
EP (1) EP0874632B1 (es)
JP (2) JP4711360B2 (es)
KR (1) KR100338829B1 (es)
CN (1) CN1132582C (es)
AP (2) AP747A (es)
AR (1) AR005456A1 (es)
AT (1) ATE220910T1 (es)
AU (1) AU713090B2 (es)
BG (1) BG63488B1 (es)
BR (1) BR9706982A (es)
CY (1) CY2390B1 (es)
CZ (1) CZ287205B6 (es)
DE (1) DE69714215T2 (es)
DK (1) DK0874632T3 (es)
DZ (1) DZ2159A1 (es)
EA (1) EA001946B1 (es)
EG (1) EG23684A (es)
ES (1) ES2180922T3 (es)
GB (1) GB9600847D0 (es)
HK (1) HK1016473A1 (es)
HU (1) HU225472B1 (es)
IL (1) IL124913A0 (es)
MX (1) MX9805713A (es)
MY (1) MY127527A (es)
NO (1) NO315689B1 (es)
NZ (1) NZ326769A (es)
OA (1) OA10812A (es)
PE (1) PE35498A1 (es)
PL (1) PL187291B1 (es)
PT (1) PT874632E (es)
SK (1) SK282132B6 (es)
TR (1) TR199800954T2 (es)
TW (1) TW434016B (es)
UA (1) UA63897C2 (es)
UY (2) UY24437A1 (es)
WO (1) WO1997025990A1 (es)
ZA (1) ZA97310B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007037790A2 (en) * 2005-06-08 2007-04-05 Elan Corporation, Plc Modified release famciclovir compositions
WO2010151893A1 (en) 2009-06-26 2010-12-29 Taris Biomedical, Inc. Implantable drug delivery devices and methods of making the same
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
CN104434852B (zh) * 2013-09-18 2018-11-20 北京韩美药品有限公司 泛昔洛韦直压片及其制备方法
CN112587491B (zh) * 2021-01-03 2022-08-23 迪沙药业集团有限公司 一种泛昔洛韦片组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421800C1 (de) * 1984-06-12 1986-04-17 Maschinen und Werkzeugbau Michael Brümmer GmbH, 8804 Dinkelsbühl Elastische Walze zum Behandeln einer thermoplastischen Folie
EP0182024B1 (en) 1984-09-20 1991-04-03 Beecham Group Plc Purine derivatives and their pharmaceutical use
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
EP0586523A4 (en) 1991-05-15 1995-11-29 Univ Yale Determination of prodrugs metabolizable by the liver and therapeutic use thereof
GB9303157D0 (en) 1993-02-17 1993-03-31 Scotia Holdings Plc Treatment of a group of related disorders
IL111138A (en) 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
JP3702594B2 (ja) * 1997-08-07 2005-10-05 株式会社明電舎 パラメータ調節方法及び装置

Also Published As

Publication number Publication date
HK1016473A1 (en) 1999-11-05
GB9600847D0 (en) 1996-03-20
ZA97310B (en) 1997-10-23
CZ225498A3 (cs) 1998-12-16
DZ2159A1 (fr) 2002-12-01
NO983259L (no) 1998-07-15
MY127527A (en) 2006-12-29
UA63897C2 (en) 2004-02-16
KR100338829B1 (ko) 2002-07-18
HUP9901021A3 (en) 2000-08-28
CY2390B1 (en) 2004-09-10
NO315689B1 (no) 2003-10-13
EP0874632B1 (en) 2002-07-24
AP1114A (en) 2002-10-18
UY24556A1 (es) 2001-08-27
ATE220910T1 (de) 2002-08-15
EG23684A (en) 2007-05-09
IL124913A0 (en) 1999-01-26
OA10812A (en) 2003-01-29
BG102638A (en) 1999-07-30
AU1541897A (en) 1997-08-11
CZ287205B6 (en) 2000-10-11
DK0874632T3 (da) 2002-11-11
WO1997025990A1 (en) 1997-07-24
AP747A (en) 1999-05-03
PL327922A1 (en) 1999-01-04
EA199800573A1 (ru) 1999-02-25
AP9801298A0 (en) 1998-09-30
PL187291B1 (pl) 2004-06-30
DE69714215D1 (de) 2002-08-29
US6765007B1 (en) 2004-07-20
CN1132582C (zh) 2003-12-31
EP0874632A1 (en) 1998-11-04
ES2180922T3 (es) 2003-02-16
SK282132B6 (sk) 2001-11-06
HUP9901021A2 (hu) 1999-08-30
JP2000503311A (ja) 2000-03-21
CN1208350A (zh) 1999-02-17
NO983259D0 (no) 1998-07-15
KR19990077229A (ko) 1999-10-25
SK95698A3 (en) 1999-01-11
TW434016B (en) 2001-05-16
BR9706982A (pt) 1999-07-20
JP4711360B2 (ja) 2011-06-29
EA001946B1 (ru) 2001-10-22
AR005456A1 (es) 1999-06-23
PT874632E (pt) 2002-10-31
MX9805713A (es) 1998-10-31
NZ326769A (en) 2000-05-26
UY24437A1 (es) 1997-06-06
JP2009091362A (ja) 2009-04-30
AU713090B2 (en) 1999-11-25
PE35498A1 (es) 1998-08-07
DE69714215T2 (de) 2003-01-23
HU225472B1 (en) 2006-12-28
AP9700911A0 (en) 1997-01-31
TR199800954T2 (xx) 1998-10-21

Similar Documents

Publication Publication Date Title
RU2401109C2 (ru) Таблетированный препарат с замедленным высвобождением для вертиго
EP3417861A1 (en) Pharmaceutical composition containing jak kinase inhibitor or pharmaceutically acceptable salt thereof
SK96497A3 (en) Valaciclovir tablet, preparation method thereof and their use
SK283872B6 (sk) Farmaceutická kompozícia, spôsob jej prípravy a jej použitie
EP0631782A1 (en) Stabilized solid pharmaceutical preparation containing dextromethorphan, phenylpropanolamine and caffeine
SK369292A3 (en) Orally administerable drugs for the treatment of central dopamine deficiency conditions
JP2009091362A6 (ja) 高含量ファムシクロビル錠剤
JP2009091362A (ja) 高含量ファムシクロビル錠剤
US20080008751A1 (en) Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof
EP0952823A1 (en) Stabilized pharmaceutical compositions and process for the preparation thereof
JP2001233766A (ja) プラバスタチンナトリウムの錠剤
KR20080112387A (ko) 2-아자-비사이클로[3.3.0]-옥탄-3-카르복실산 유도체의 안정한 약학 조성물
BG61242B2 (bg) Твърд фармацевтичен състав за орална употреба набаза дапипразол
US6737419B2 (en) Benazepril hydrochloride tablet formulations
CA2240462C (en) High-content famciclovir tablets
EP1889629B1 (en) Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof
KR20200084649A (ko) 약학 조성물
EP3372227A1 (en) Tablet formulation of adefovir dipivoxil
CA2659814A1 (en) Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof
KR20090021222A (ko) 수분 민감성 약물 및 제2 약물의 배합을 포함하는 안정한 제제 및 이의 제조 방법